Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma.
Huang SZ, Wei MN, Huang JR, Zhang ZJ, Zhang WJ, Jiang QW, Yang Y, Wang HY, Jin HL, Wang K, Xing ZH, Yuan ML, Li Y, He XS, Shi Z, Zhou Q.
Huang SZ, et al. Among authors: li y.
Front Oncol. 2019 Mar 15;9:150. doi: 10.3389/fonc.2019.00150. eCollection 2019.
Front Oncol. 2019.
PMID: 30931258
Free PMC article.